Measuring persistence of implementation: QUERI Series by Bowman, Candice C et al.
BioMed  Central
Page 1 of 13
(page number not for citation purposes)
Implementation Science
Open Access Debate
Measuring persistence of implementation: QUERI Series
Candice C Bowman*1, Elisa J Sobo2, Steven M Asch3, Allen L Gifford4 for the 
HIV/Hepatitis Quality Enhancement Research Initiative
Address: 1Health Services Research & Development, VA San Diego Healthcare System, San Diego, California, USA, 2Department of Anthropology, 
San Diego State University, San Diego, California, USA, 3Center for the Study of Healthcare Provider Behavior, VA Greater Los Angeles Healthcare 
System, Los Angeles, California, USA and 4Center for Health Quality, Outcomes, and Economic Research, VA New England Healthcare System, 
Bedford, Massachusetts, USA
Email: Candice C Bowman* - candybowman@gmail.com; Elisa J Sobo - esobo@mail.sdsu.edu; Steven M Asch - steven.asch@va.gov; 
Allen L Gifford - agifford@bu.edu
* Corresponding author    
Abstract
As more quality improvement programs are implemented to achieve gains in performance, the
need to evaluate their lasting effects has become increasingly evident. However, such long-term
follow-up evaluations are scarce in healthcare implementation science, being largely relegated to
the "need for further research" section of most project write-ups. This article explores the variety
of conceptualizations of implementation sustainability, as well as behavioral and organizational
factors that influence the maintenance of gains. It highlights the finer points of design considerations
and draws on our own experiences with measuring sustainability, framed within the rich theoretical
and empirical contributions of others. In addition, recommendations are made for designing
sustainability analyses.
This article is one in a Series of articles documenting implementation science frameworks and
approaches developed by the U.S. Department of Veterans Affairs Quality Enhancement Research
Initiative (QUERI).
Background
When quality improvement (QI) programs reach initial
success but fail to maintain it, the need for guidance in
evaluating the lasting effects of implementation becomes
evident. However, any real measurement of long-term
effects is rare and sporadic in the burgeoning discipline of
healthcare implementation science. Akin to other aspects
of healthcare, such as the pharmaceutical industry's post-
marketing phase of pharmacovigilance for monitoring
ongoing drug quality and safety, more prospective studies
that follow implementation program dynamics over the
long term are needed. As things stand, very little is known
about what eventually happens to outcomes – or whether
new programs even still exist after implementation is
completed [1].
This article is one in a Series  of articles documenting
implementation science frameworks and approaches
developed by the U.S. Department of Veterans Affairs
(VA) Quality Enhancement Research Initiative (QUERI).
QUERI is briefly outlined in Table 1 and is described in
more detail in previous publications [2,3]. The Series'
introductory article [4] highlights aspects of QUERI that
are related specifically to implementation science, and
describes additional types of articles contained in the
Series. In this case, the focus is on a key measurement
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issue – sustainability, which is a discrete component of
the QUERI model's fourth phase of refinement and
spread.
We explore the concept of sustainability and related
design considerations in the context of our experiences
from a QUERI project, where we sought to measure
whether implemented changes were sustained (see Table
2 for project details). Such knowledge is essential to the
creation of durable, exportable implementation products
that can be broadly rolled-out across the VA healthcare
system, an expectation consistent with the QUERI frame-
work.
HIV/Hepatitis QUERI Center project
In a complex and lengthy implementation project, we
compared the separate and combined effects of real-time,
computerized clinical reminders and group-based quality
improvement collaboratives at 16 U.S. Department of Vet-
erans Affairs (VA) healthcare facilities for one year, in
order to evaluate each intervention, as well as the interac-
tion of the two, in improving HIV care quality [5]. Then,
to ascertain whether performance gains associated with
the implemented interventions were sustained and
whether or not they had become part of routine care (i.e.,
had been 'routinized'), we sought guidance from the
related literature about how to measure ongoing perform-
ance and continued use of the interventions during a fol-
low-up year.
Questions regarding sustaining QI have been addressed in
existing work (e.g., Greenhalgh et al. [6], Fixsen et al. [7],
and Øvretveit [8]); however, we failed to find enough
detail in this literature to actually direct the design and
conduct of a sustainability analysis. Therefore, in this arti-
cle we strive to provide such direction. First, we briefly
explore what is known about the lasting effects of quality
improvement interventions in regard to long-term behav-
ior change, as well as knowing why gains achieved in per-
formance often fail after implementation. We then
provide guidance for implementers interested in measur-
ing not just whether QI changes were likely to sustain, but
whether they actually did. We describe important consid-
erations for designing such an analysis, drawing from our
own effort, and also framed within the rich theoretical
and empirical contributions of others.
The concept of sustainability
Simply describing implemented interventions as suc-
cesses or failures leaves too much room for interpretation:
What is 'success?' What is 'failure?' What is the timeline by
which such conclusions are drawn?
A first step to correcting these ambiguities is making a
strong distinction between achieving improvement in out-
comes and sustaining them. Achieving improvements gen-
erally refers to gains made during the implementation
phase of a project that typically provides a generous sup-
ply of support for the intervention, in the way of person-
nel and other resources. However, sustaining
improvements refers to "holding the gains" [p.7, [8]] for a
variably defined period after the funding has ceased and
project personnel have been withdrawn – an expectation
identified as a major challenge to the longevity of public
Table 1: The VA Quality Enhancement Research Initiative (QUERI)
The U.S. Department of Veterans Affairs' (VA) Quality Enhancement Research Initiative (QUERI) was launched in 1998. QUERI was designed to 
harness VA's health services research expertise and resources in an ongoing system-wide effort to improve the performance of the VA healthcare 
system and, thus, quality of care for veterans.
QUERI researchers collaborate with VA policy and practice leaders, clinicians, and operations staff to implement appropriate evidence-based 
practices into routine clinical care. They work within distinct disease- or condition-specific QUERI Centers and utilize a standard six-step process:
1) Identify high-risk/high-volume diseases or problems.
2) Identify best practices.
3) Define existing practice patterns and outcomes across the VA and current variation from best practices.
4) Identify and implement interventions to promote best practices.
5) Document that best practices improve outcomes.
6) Document that outcomes are associated with improved health-related quality of life.
Within Step 4, QUERI implementation efforts generally follow a sequence of four phases to enable the refinement and spread of effective and 
sustainable implementation programs across multiple VA  medical centers and clinics. The phases include:
1) Single site pilot,
2) Small scale, multi-site implementation trial,
3) Large scale, multi-region implementation trial, and
4) System-wide rollout.Implementation Science 2008, 3:21 http://www.implementationscience.com/content/3/1/21
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health programs [9]. For this reason, it behooves imple-
mentation scientists to keep the longer view in mind
when designing interventions, including those that poten-
tially will be exported to other venues.
To paraphrase Fixsen and colleagues, the goal of sustaina-
bility is not only the long-term survival of project-related
changes, but also continued effectiveness and capacity to
adapt or replace interventions or programs within con-
texts that constantly change [7]. Thus, sustainability also
can refer to embedding practices within an organization
[6,10-14]. Failure to do so can be a result of either a poor
climate for implementation or poor commitment by users
because of a misfit with local values [15].
For measurement purposes, this multi-faceted definition
needs to be understood and sustainability addressed early
in a project. Such an assessment would be unlikely with-
out a proper formative evaluation (FE) built into the orig-
inal study design [16], as discussed below. This includes
assessment of relapse. Although some degree of backslid-
ing happens in any attempt to change behavior, relapsing
to old behaviors should be accounted for [10,11]. From a
measurement perspective, a decision has to be made
regarding how much relapse can be tolerated and still
allow investigators to call the new behavior sustained.
As the mention of backsliding suggests, sustainability, as
we define it, differs from – but may depend upon – repli-
cation when the innovation is expected to spread to addi-
tional units or sites within an organization. Similar to
fidelity, replication is concerned with how well an inno-
vation stays true to the original validated intervention
model after being spread to different cohorts [17]. [We
Table 2: QUERI-HIV/Hepatitis implementation project summary
MAIN IMPLEMENTATION PROJECT:
Background: Although studies have shown that real-time computerized clinical reminders (CR) modestly improve essential chronic disease care 
processes, no studies have compared the separate and combined effects of CR and group-based quality improvement (GBQI) 
collaboratives.
Objectives: To evaluate CR, GBQI, and the interaction of the two in improving HIV quality (Step 4, Phase 2 per the QUERI framework).
Methods: Using a quasi-experimental design, 4091 patients in 16 VA facilities were stratified into four groups: CR, GBQI, CR+GBQI, and 
controls. CR facilities received software and technical assistance in implementing real time reminders. GBQI facilities participated in 
a year-long collaborative emphasizing rapid cycle quality improvement targets of their choice. Ten predefined clinical endpoints 
included the receipt of highly active antiretroviral (ARV) therapy, screening and prophylaxis for opportunistic infection, as well as 
monitoring of immune function and viral load. Optimal overall care was defined as receiving all care for which the patient was 
eligible. Interventional effects were estimated using clustered logistic regression, controlling for clinical and facility characteristics. 
Human subjects' protection approval was obtained.
Results: Compared to controls, CR facilities improved the likelihood of hepatitis A, toxoplasma, and lipid screening. GBQI alone improved 
the likelihood of pneumocystis pneumonia prophylaxis, immune-monitoring on ARVs – but reduced the likelihood of hepatitis B 
screening. CR+GBQI facilities improved hepatitis A and toxoplasma screening, as well as immune-monitoring on ARV. CR+GBQI 
facilities improved the proportion of patients receiving optimal overall care (OR = 2.65; CI: 1.16–6.0), while either modality alone 
did not.
Conclusions: The effectiveness of CR and GBQI interventions varied by endpoint. The combination of the two interventions was effective in 
improving overall optimal care quality.
SUSTAINABILITY ANALYSIS SUPPLEMENT:
Objectives: To ascertain whether the implemented interventions were sustained and became part of routine care, we measured the original 
outcomes for one additional year and evaluated continued intervention use at selected sites.
Methods: Interviews with key informants selected from the study sites revealed that some sites had ceased using the interventions, and some 
control sites had adopted them; analyzing odds of patients receiving guideline-based HIV care (HIVGBC) compared to controls no 
longer made sense. Thus, we evaluated sustained performance as follows: At the facility-rather than the arm-level, we examined raw 
rates of patients receiving HIVGBC at only those facilities in the intervention arms that had significant effects in the study year to 
determine whether they continued to show a significant increase in these rates in the following year, compared to their raw rate at 
baseline. We also conducted a qualitative component. Based on formative evaluation results assessing the use and usefulness of the 
reminders, we asked informants if identified barriers were subsequently removed and recommendations heeded. Also, we evaluated 
the extent to which staff members from the sites that participated in the collaboratives were still conducting rapid-cycle 
improvement methods to address local care quality problems; whether they still maintained the social networks established during 
the original study, and the degree to which they were used to disseminate subsequent quality improvement change ideas, and shared 
network contacts with – and taught the method to new staff.
Results: For hepatitis A screening, we found that 4 out of the 5 sites that showed a significant increase in their raw rate at 12 months, also 
showed a significant increase in their raw rate at 24 months compared to baseline (p = .05). For the other four significant indicators 
of HIVGBC (hepatitis C and toxoplasma screening, CD4/viral load and lipids monitoring), all sites that showed significant increases in 
their raw performance rates at 12 months, showed a significant increase in their raw rates at 24 months compared to baseline.
Conclusions: Intervention effects were sustained for one year at nearly all the sites that showed significant increases in performance during the 
study period. Nearly all sites exposed to reminders were using at least some of the 10 available in the follow-up year. Collaborative 
methods were still being used, but only at the most activated of the original study sites.Implementation Science 2008, 3:21 http://www.implementationscience.com/content/3/1/21
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use 'validated' not to indicate testing in highly controlled
settings, but rather in regard to testing in more typical,
real-time circumstances.] Racine argues that sustained
effects can be achieved only through the reliable spread of
an innovation, or the faithful replication of it [18].
Slippage of the intervention from the original achievement
of change related to its core elements can occur as a result
of influences from multiple levels of the organization, due
to, for example, local staffing conditions, administrators
losing interest, or changes in organizational goals. Slippage
can be limited through performance monitoring, standards
enforcement, and creating receptive subcultures [19], all
strategies requiring some degree of infrastructure support.
Yet, shortage of such support is precisely why many QI
interventions eventually disappear.
There are four prerequisites for realizing program benefits
over time: 1) adequate financial resources, 2) clear
responsibility and capacity for maintenance, 3) an inter-
vention that will not overburden the system in mainte-
nance requirements [20], and 4) an intervention that fits
the implementing culture and variations of the patient
population [21]. Skeptics may argue that these organiza-
tional components rarely coincide in the real world. Some
see standardizing QI interventions as a pitfall that should
be avoided, while some seem less worried about the neg-
ative effects of variation because they see it as a necessary
adaptation to local environments [22,23]. Preventing
adaptation at this level may explain why an intervention
did or did not sustain, so imposing fidelity can be a dou-
ble-edged sword. This can be better understood and clari-
fied by measuring it through both the project's FE and,
later, in the follow-up analysis.
To construct an informative definition of sustainability, it
is important to keep in mind the fundamental objective of
implementation and QI: To improve patient health. For
example, effectiveness measured by number of smoking
quits or higher screening rates for at-risk patients are typi-
cal of implementation project objectives; actual improve-
ments in morbidity and mortality are the inferred
endpoints of interest. The overarching concern of any QI
effort should be for an intervention or program that sur-
vives long enough to lead to improvements in patient
health that can be measured. That being said, establishing
the relationship between a particular QI strategy and its
related health outcome(s) may be somewhat ambitious
considering the barriers [24].
Following Øvretveit [8], we conceptually define sustaina-
bility in two ways: 1) continued use of the core elements
of the interventions, and 2) persistence of improved per-
formance. Operationally defining and measuring 'contin-
ued use,' 'core elements,' 'persistence,' and 'improved
performance' was a challenge for us – an experience that
formed the basis of this article.
Factors affecting sustainability and its measurement
Spreading innovations within service organizations can
range from "letting it happen" to "making it happen,"
depending on the degree of involvement by stakeholders
[6]. The former passive mode is unprogrammed, uncer-
tain and unpredictable, whereas, the latter active mode is
planned, regulated and managed [25].
Consider the three situations in Figure 1. In each, per-
formance improvements, shown on the vertical axes,
decline when the active phase ends although each ulti-
mately represents a different outcome. In the first situa-
tion, the active phase shows initial gains (i.e.,
sustainability success) but performance still decays some-
what when support is withdrawn. However, given a suffi-
ciently receptive environment, improvements can remain
above the baseline level in the long-term. Alternatively,
the second curve shows performance returning to base-
line, and in the worst case, dropping below it, indicating
sustainability failure. Although either the first or second
circumstance could result from a situation where support
for the intervention is relatively passive, active mainte-
nance may make all the difference in long-term success;
and sustainability failure seems particularly likely if the
level of support provided for the intervention during
implementation is withdrawn after its completion (e.g.,
enriched clinic staff, research assistants, leadership
endorsement).
In the final situation, which clearly reflects an active
mode, a successfully implemented intervention with fol-
low-up booster activity at certain intervals sustains per-
formance improvements, albeit in a somewhat saw-tooth
pattern. Declines are attenuated as a result of the periodic
nudge, as without occasional reinforcement or higher
order structural changes to encourage institutionalization
of the new 'steady state,' the new behavior will eventually
decay or revert back to its previous state.
In identifying a need for a better model of the mainte-
nance process in health behavior change, Orleans argued
that more effort should be focused on maintenance pro-
motion rather than on relapse prevention [26]. Yet, how
much do we really know about what is needed to prevent
slips and relapses from occurring until an intervention
with its associated performance gains is institutionalized?
This question cannot begin to be answered until one
knows whether implemented change has actually suc-
ceeded or failed in the longer term, and to know that, it
has to be measured.Implementation Science 2008, 3:21 http://www.implementationscience.com/content/3/1/21
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Being cognizant of models describing human behavior
and lifestyle change may benefit the selection of suitable
sustainability measures to study the behavior of providers
and organizations. Models most frequently used are based
on assumptions that people are motivated by reason or
logic, albeit within contexts influenced by social norms or
beliefs (e.g., Health Beliefs Model [27] and Theory of Rea-
soned Action [28]). However, logic is not always a pri-
mary driver of behavior [29] but when it is, the logic may
be generated in regard to cultural or structural factors (i.e.,
peer norms or an individual's relationship with his/her
supervisor). Measures that capture information about
what drives continued participation in QI efforts would
be useful.
While change through the internalization of new proc-
esses is essential for sustaining implementation, one fac-
tor that we have observed to be associated with
sustainability failure is a lack of systems-thinking. That is,
to capitalize on gains made during the active phase, and
to design proper sustainability measures, one must view
organizations as complex, adaptive systems [30]. In such
systems, processes that promise to be inherently (albeit
unintentionally) supportive of the anticipated change can
be leveraged with careful planning to both generate and
maintain a QI change. Because routinization of innova-
tions drives sustainability, measures should take into con-
sideration the degree to which a given practice has been
woven into standard practice at each study site, such as its
centrality in the daily process flow and its location in the
practice models held and adhered to by personnel [31,32]
(e.g., the Level of Institutionalization instrument or LoIn
[12]).
Measuring sustainability as persistence
In seeking examples of studies that included any degree of
follow-up evaluation, we found that evaluation of health
promotion programs, primarily in regard to improving
individual behavior, and continued concordance with
treatment guidelines after implementation or dissemina-
tion, targeting either provider or organizational perform-
ance, were the two most common foci. This is similar to
what Greenhalgh's group found in searching for reports
on diffusion of service innovations [6]. Overall, however,
our impression, like others' [6], was that reported analyses
of sustained effects are rare (see Table 3 for examples from
our search). We speculate that this scarcity is due to one or
more of the following reasons.
￿ Since there must be a time gap between when a QI study
ends and when sustainability can be appropriately meas-
ured, finding a suitable funding mechanism can be a chal-
lenge.
￿ An analysis of sustainability, especially if designed post
hoc, is limited in what can be evaluated.
￿ Good measures of sustainability are not common and/
or not immediately obvious, depending on the clarity of
one's operational definition of sustainability.
We differentiate between sustainability analyses that are
premeditated (e.g., included in an implementation
project's formative evaluation and those designed after
the fact. The fundamental difference between the two is
that the former is limited to measuring the likelihood that
changes  will sustain, as the project will end before the
maintenance period occurs. There are several measures
that could be included in an FE that would elucidate and
potentially enhance realization of this concept [16]. The
latter type of analysis is limited to measuring whether use
of the intervention or performance gains actually did sus-
tain without an ability to influence the probability of that
occurrence. The LoIn instrument [12] is perhaps the single
best example of this latter approach.
Three possible outcomes of performance improvement: Suc- cessful, failed, and enhanced Figure 1
Three possible outcomes of performance improve-
ment: Successful, failed, and enhanced. (T1 = baseline 
period, T2 = implementation period, T3 = follow-up period).Implementation Science 2008, 3:21 http://www.implementationscience.com/content/3/1/21
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Table 3: Examples of studies reporting follow-up evaluation of implemented interventions
Authors Design Intervention Intervention 
target
Intervention 
length
Outcome 
measured
Post-
intervention 
sustainability 
period
Knox et al., 2003 
[46]
Quasi-experiment, 
pre-post 
comparison
Multi-component 
suicide prevention 
program
USAF personnel 
(patient-level)
1 year Relative suicide 
risk factor rates
1 year
Harland et al., 
1999 [47]
RCT, pre-post 
comparison
1–6 motivational 
interviews, with or 
without financial 
incentive
General medicine 
practice patients 
(patient-level)
3 months Self-reported 
physical activity
1 year
Shye et al., 2004 
[48]
Multi-faceted 
intervention trial, 
pre-post 
comparison
(1) Basic strategy: 
guideline, 
education, clinical 
supports
(2) Augmented 
strategy: basic 
program with 
social worker 
added
HMO PCPs 
(provider-level)
10 months Rates of female 
patients who 
asked about 
domestic violence
3 months
Sanci et al., 2000, 
2005 [49,50]
RCT, pre-post 
comparison
Multi-faceted 
adolescent health 
education program
General medicine 
practice physicians 
(provider-level)
3 months Observer ratings 
of skills, self-
perceived 
competency, 
tested knowledge
4 months, 10 
months, 5 years
Perlstein et al., 
2000 [51]
Pre-post 
comparison
Implemented 
bronchiolitis care 
guideline
Pediatricians who 
cared for infants 
0–1 year 
hospitalized with 
bronchiolitis 
(provider-level)
-- Patient volumes, 
length of stay, use 
of ancillary 
resources
3 years
Brand et al., 2005 
[52]
Program 
evaluation
COPD 
management 
guideline
Hospital physicians 
(provider-level)
-- Guideline 
concordance, 
attitudes and 
barriers to 
guidelines, access 
to available 
guidelines
2 years
Morgenstern et al., 
2003 [53]
Quasi-experiment, 
pre-post 
comparison
Multi-component 
acute stroke 
treatment 
education program
Community 
laypersons 
(patient-level); 
Community- and 
ED-based 
physicians and 
EMS responders 
(provider-level); 
Stroke care 
policies 
(organization-
level)
15 months Number of acute 
stroke patients 
who received 
intravenous tissue 
plasminogen 
activator
6 months
Bere et al., 2006 
[54]
Controlled trial, 
pre-post 
comparison
(1) Fruit and 
vegetable 
education program
(2) No-cost access 
to school fruit 
program
School-age 
students (patient-
level)
1 year All-day fruit and 
vegetable intake
1 year
Shepherd et al., 
2000 [55]
Systematic review 
of controlled 
comparisons with 
pre-post analysis
Health education 
interventions that 
promote sexual 
risk reduction in 
women
Sexually active 
women in any 
setting, treated by 
any provider type 
(patient-level)
Varied from 1 day 
to 3 years (most 
lasted 1 to 3 
months)
Behavioral 
outcomes (e.g, 
condom use, 
fewer partners, or 
abstinence, fewer 
STDs)
Varied from 1 
month to 6 
months (most 
were up to 3 
months)
Note. To identify studies that measured sustainability, we searched PubMed for reports that included any follow-up analyses of interventions or 
program effects, using keyword searches for terms such as 'sustain,' 'sustained,' 'sustainability,' and 'follow-up.'Implementation Science 2008, 3:21 http://www.implementationscience.com/content/3/1/21
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With enough forethought and funding, using both pre-
meditated and post hoc approaches would be optimal.
However, without the value of forethought we conducted
a post hoc-designed evaluation and, in doing so, realized
how uncertain we were about what to measure, when and
how to measure it, and how to get funded to do so. What
follows is a synthesis of what we learned from our own
observations and what useful insights we gleaned from
the relevant literature about designing a sustainability
analysis of either type.
What to measure
The goal of QUERI implementation is to create effective
innovations that remain robust and sustainable under a
dynamic set of circumstances and thus ensure continued
reduction in the gaps between best and current practices
associated with patient outcomes. Hence, knowing pre-
cisely what has been sustained becomes important from a
performance and thus measurement perspective – and
therein lies the challenge. Relative to long-term effective-
ness, what is it about the intervention or program that
should survive? And what about the organizational con-
text needs to be understood in order to adequately inter-
pret what the results mean? The following provide one set
of dimensions of improvements that can potentially be
turned into critical measures of sustainability, depending
on whether the analysis is part of a project FE or con-
ducted post hoc. These dimensions include: 1) interven-
tion fit, 2) intervention fidelity, 3) intervention dose, and
4) level of the intervention target.
Intervention fit
Effective interventions targeting any level of the organiza-
tion are not necessarily enduringly useful ones. There is
good evidence showing that interventions that are not
carefully adapted to the local context will not endure [6].
Sullivan and colleagues described a 'bottom-up' approach
using provider input to design a QI program that
increased provider buy-in and, hence, sustainability of the
intervention [33]. When improvements fail to persist, the
researcher's challenge is in drawing the right conclusion
about whether the intervention failed because of external
influences that occurred after the intervention period, or
because it was not considered to be all that useful to the
organization in the long-run [15].
In our study, we suspected that sites that were marginally
enthusiastic about participating in the modified collabo-
rative may have felt obliged to participate for the sake of
the project, but in actuality, failed to perceive any benefit
for the long-term. Modest enthusiasm most likely
explains some of the poor performance observed. Collab-
orative participation, as part of our strategy for continu-
ous quality improvement (CQI), could not – and did not
for some in our project – work with such an attenuated
level of interest. More diagnostic FE [16] might have
enhanced our intervention mapping to identify and
address this issue early on. ('Intervention mapping' is a
borrowed term that describes the development of health
promotion interventions and refers to a nonlinear, recur-
sive path from recognition of a problem or gap to the
identification of a solution [34].
Implemented interventions generally consist of multiple
components, some of which do not demonstrate success.
Solberg et al. found that bundling guidelines into a single
clinical recommendation is more acceptable to the pro-
viders who are meant to follow them [35]. However, in
the reminder study arm, we implemented a clinical
reminder package that consisted of automated provider
alerts for 10 separate aspects of evidence-based HIV treat-
ment. Despite the incomplete success of the full software
package (i.e., all the alerts in the package did not generate
improvements) it was rolled out intact based on a policy
decision. Since sustainability was not an issue for the
reminders in the package that had failed to produce signif-
icant performance improvements during the project, we
simply did not analyze their individual effects in the
quantitative aspect of the follow-up sustainability assess-
ment. During interviews with key site-based informants
after the study was completed, we learned that some of the
implemented reminders were not regarded as helpful by
local clinicians in making treatment decisions, which
helped us explain their failure to produce significant
improvements. In more complex, multi-faceted QI inter-
ventions, components should not be so inextricably
linked, so that independent evaluation of successful ones
is still possible.
Intervention fidelity
Because of the general complexity of implementation
interventions, it is important to evaluate the discrepancy
between what the intervention was like in the original
implementation versus what it becomes when sustaina-
bility is subsequently measured. Inability to unequivo-
cally credit improvements to a particular intervention
within a complex improvement strategy is a common
shortcoming of QI research [1]. 'Outcome attribution fail-
ure' can be a major, and sometimes insoluble, problem in
this type of analysis, making it imperative to fully grasp
how an intervention morphs with each new implementa-
tion unit, at each new site or new phase of roll-out.
Wheeler [36] recalls the contributions of Shewhart's 1931
report on controlling variation in product quality in the
manufacturing industry. An important message from his
work is that normal variations should be differentiated
from those that have 'assignable causes,' which create
important but undesirable changes in the product over
time.Implementation Science 2008, 3:21 http://www.implementationscience.com/content/3/1/21
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Although all components of the reminder package were
offered to all VA sites after our project's completion, we
made no attempt to control local drift in the software or
its usage. This could have clouded interpretation of per-
formance in the sustainability period, if we had not inter-
viewed key informants about which specific reminders
were still being used and under what circumstances.
While quantifying the amount of drift in the way that the
reminders were being used would have been preferable,
we were at least able to describe variation that occurred
based on local need or preference.
The QUERI framework recommends enhancing and sus-
taining uptake with ongoing or periodic monitoring at the
local level to lower the fidelity gap, because rarely is the
first iteration of an intervention perfect. Local adapta-
tions/variations are not, within the caveat of staying true
to the actual basis of the targeted best practice, anathema
to the four-phased QUERI model, especially if they are
designed on an appropriate rationale to actually improve
goal achievement. However, it is clear that changing cir-
cumstances within the organizational environment can be
a significant threat to sustainability. Implementation
researchers could use more guidance about how to distin-
guish between the core features of an intervention that
should not be allowed to drift, and those features that can
be adapted. In any event, understanding how an innova-
tion may have been adapted over time, or why it was dis-
continued are both important to assess when trying to
determine the black box of implementation and its ongo-
ing effects, especially during the early stages of a phased
roll-out when refinements can, and should, be made.
Therefore, understanding and implementing desirable
changes to an intervention should be part of the overall
implementation strategy.
Intervention dose
The longevity of an adopted intervention may be a direct
function of original implementation intensity. The twin
concepts of 'dose delivered' and 'dose received', referring
to the amount of exposure to and uptake of an implemen-
tation intervention [37], provide a focus for related meas-
urement, although only the latter is important to a post
hoc-designed analysis. To measure the dose received in a
post hoc analysis, a researcher would ask what proportion
of the intervention was still being used by the intended
targets. After we implemented the study collaborative in
our project, a national VA HIV collaborative was con-
ducted during the follow-up year. Based on key informant
interviews, sites in the study collaborative that subse-
quently participated in the national collaborative seemed
more enthusiastic about continuing to use collaborative
strategies for continuous quality improvement. For exam-
ple, in terms of the use of social networks for sharing QI
information and usage of Plan-Do-Study-Act (PDSA)
cycles to address new quality problems. We saw this as a
clear indication of dose response, which makes a case for
incorporating measurement of any booster activity, either
prospectively as part of the project's FE, or retrospectively
as part of the sustainability analysis.
Intervention target
Measuring sustainability depends on the change that is
targeted and whether the focus of the intervention is the
individual (i.e., provider or patient) or the organization
(i.e., facility or integrated healthcare system), or both.
Implementing change at one level while taking into con-
sideration the context of the others (e.g., individual versus
group, facility, or system), will produce the most long-
lasting impact [38]. Effecting changes in individual versus
organizational performance are qualitatively different
tasks that require not only different instruments for meas-
uring changes, but acquisition of in-depth knowledge of
the processes that control adoption or assimilation of the
innovation at either level [6]. Activities associated with
the project's FE, such as assessment of facilitators and bar-
riers, will facilitate this latter aspect.
Our implementation targets were individual providers who
operate within the small HIV clinic environment at each VA
medical center. However, buy-in and support from clinic
leadership was an obvious factor impacting implementa-
tion effectiveness of both system interventions [39]. Our
sustainability analysis did not include a repeat of this
assessment, but, in hindsight, its inclusion would have
facilitated our interpretation of performance and usage in
our follow-up. Just as targeting levels of individual and
organizational behavior provide an important framework
to maximize success of implementation efforts, being
mindful of what happens at multiple levels after the project
also applies to measuring success of sustained QI.
Sustainability measurement should flow logically from
and within the overall project evaluation, thus highlight-
ing the limitations of our post hoc type of approach. How-
ever, measuring some of these critical dimensions as part
of the project's FE will go a long way toward explaining
why an intervention failed or succeeded in the long-run.
When to measure
The amount of time that is necessary to follow interven-
tion effects and/or usage is quite variable. In the examples
listed in Table 3, evaluations lasted anywhere from several
months after implementation to several years. Ideally, one
would keep measuring performance – and contextual
events – until decline shows some indication of stabiliz-
ing or the intervention is no longer useful. Some may
argue that the more astute investigator will specify the
length of the follow-up period based on a theoretical per-
spective because then, if the follow-up plan becomesImplementation Science 2008, 3:21 http://www.implementationscience.com/content/3/1/21
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altered, they can at least appeal to theory to assess confi-
dence in their results. Because we were limited by funding
in our own analysis, the follow-up period was artificially
restricted to one year past the end of active implementa-
tion. Another difficulty in timing sustainability measure-
ment, described by Titler [40], is knowing where to draw
the line between the implementation and follow-up peri-
ods. Distinguishing between lingering improvements
from the implementation and true persistence of effects
from institutionalization also is a challenge [40].
In our post hoc analysis, we examined rates of indicated
care received by eligible patients at sites within each inter-
vention arm that yielded a significant performance gain
during the study year, in order to determine whether that
gain persisted in the following year. Figure 2 shows actual
performance measurements from our study for appropri-
ate hepatitis A screening in patients with HIV in three time
periods: 1) 12 months prior to launch, 2) during the year-
long implementation, and 3) during 12 months of follow-
up. Judging from the downward trends in screening per-
formance, we probably did not capture the performance
nadir, so one year was probably not enough. Our decision
to use a one-year follow-up was admittedly arbitrary and
based somewhat on symmetry, given that the two earlier
periods also were that length. Ideally, the evaluation
period should be long enough to capture the lowest level
to which performance will naturally decline, either with
or without booster efforts to determine success or failure.
The amount of time it takes to measure long-term effects
is dependent on the speed of spread [6]. QUERI research-
Site-level performance for hepatitis A screening in HIV patients before, during and after a one-year-implementation trial Figure 2
Site-level performance for hepatitis A screening in HIV patients before, during and after a one-year-imple-
mentation trial. Indicated by letter and number, sites implemented either clinical reminders (R), collaboratives (C), or both 
(C+R).Implementation Science 2008, 3:21 http://www.implementationscience.com/content/3/1/21
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ers are not always actively involved in exporting successful
QI strategies to other parts of the VA system, thereby mak-
ing it difficult to know the level of penetration when fol-
low-up evaluation is conducted. Yet due to our close
collaboration with the VA central office responsible for
HIV care delivery, we did have access to information
regarding the level of penetration of our study interven-
tions. Knowing what was happening in the field enabled
us to gauge the effects of external events, such as the tim-
ing in regard to readiness for subsequent exportation of
the reminder software, as well as the schedule for the
national collaborative. Then again, there is the temptation
for some to use unanticipated external events to excuse a
failed intervention. Sustainable QI should be robust to
these influences.
CQI methodology dictates that internal follow-up meas-
urement is needed as long as the intervention or program
remains useful to the organization [41]. Adding to that,
our recommendation for estimating how long to follow
performance after implementation would be that 'longer
is always better,' although what is feasible rightfully tends
to override any other consideration. In translating tenets
of CQI to the four-phased QUERI implementation model
described in Table 2, the principle remains the same.
However, the responsibility for follow-up changes at each
phase, such that a move toward creating routine national
performance measures should be considered at national
roll-out.
How to measure
Methods used in evaluating the success of implemented
QI interventions and strategies are 'messy' at best, and
measuring their longer-term effects is no different. A
number of designs have been recommended. Focused
audit studies have a built-in cycle for monitoring QI
impact against accepted and expected standards over time
[42]. Other approaches include single case studies and
quasi-experimental pre/post-test comparisons [43]. We
used the latter design to evaluate the implementation of
the clinical reminders and collaborative, although this
type of design presented our major challenge in evaluat-
ing intervention sustainability for two reasons. First, the
non-intervention sites became contaminated after the ini-
tial study period because they were allowed to adopt the
reminders and participate in the national collaborative,
thus preventing any further utility as a comparison group.
Second, this snapshot-type of approach prevented a more
finely grained examination of when the level of decay
might have warranted booster treatments.
Although the lack of an effective control group was not a
problem that we could remedy, a more robust approach
would have been to use a time-series design [44]. Ideally,
the analytic window would have included monthly meas-
urements over the entire 24-month period, while restrict-
ing spread of the interventions to the control sites during
that time. In hindsight, multiple measurements during
the follow-up phase at the very least would have allowed
us to take advantage of this potentially useful informa-
tion.
Because our follow-up analysis was not included as a com-
ponent of the original design, our default post hoc strat-
egy was to compare rates of patients receiving evidence-
based HIV care at only those facilities in the intervention
arms that had significant effects in the study year relative
to their own rates at baseline. Unfortunately, this
approach kept us from associating durability of the effects
with a particular intervention, as well as from making site-
to-site comparisons. As a result, we were unable to con-
duct multivariate analyses, although we were able to
assess whether improved performance for sites that
showed success on certain quality indicators during
implementation did persist past the study period. How-
ever, finding the right approach to long-term evaluation,
given the limits imposed by lack of resources constricting
a system's desire to adopt promising interventions, can be
a significant barrier to forming valid conclusions about
sustainability.
Quantitative methods, however complex, are best suited
for measuring ongoing performance, but evaluating
implementation interventions or program/strategy usage
requires methods that yield more texture and detail (i.e.,
observation and interviews). May and colleagues evalu-
ated the sustainability of telemedicine services in three
projects over five years using such qualitative techniques,
enabling them to better determine the how and the why
of their empirical results [14]. Similarly, in addition to
measuring clinical endpoints, we conducted semi-struc-
tured telephone interviews with two key informants from
each of the sites that we felt best characterized a particular
type of site from each intervention arm. For example, a
site that participated in the study collaborative and the
national collaborative was chosen, as well as one that par-
ticipated in the study collaborative only. Answers to ques-
tions regarding the existence of known barriers to
reminder use and continuation of collaborative activities
enhanced our ability to interpret the quantified results.
Implementation barriers and facilitators identified during
a project's FE also should be taken into account in design-
ing follow-up sustainability analyses. Based on one com-
ponent of our project's FE regarding the use and
usefulness of the reminders [45], we asked our informants
during follow-up if the barriers described in the human
factors analysis were subsequently removed and recom-
mendations for procedural modifications heeded. For
those sites where barriers had been removed, we were ableImplementation Science 2008, 3:21 http://www.implementationscience.com/content/3/1/21
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to conclude that observed performance during the follow-
up phase was not a result of the persistence of those barri-
ers.
How to get funded
Finding financial support to conduct an evaluation of sus-
tained effects will more than likely be a high hurdle for the
action-oriented implementation researcher, at least
within the U.S., since the traditional three-year grant is
rapidly giving way to a shorter and leaner version that
obviates any follow-up analyses. Justifying the addition of
a fallow period after completion of a project would have
been difficult before – and now is virtually impossible
without a funded extension. Funded extensions for
research grants are rare, although small grants for focused,
short-term projects are becoming more common. Such
small grants are sufficient to conduct a brief sustainability
analysis, as long as the scope is limited and the plan for
the evaluation and human subjects' approval is already in
place. One caveat for pursuing rapid turnaround grants,
such as the one that funded our analysis, is that they may
limit the latitude of a qualitative component, in particu-
lar, since those analyses are generally more time and
resource consuming.
Another option is to entrust the measurement to others.
There is a role for the implementation researcher in
encouraging participating clinical entities to take on the
tasks of monitoring and assessing their own performance.
For this to happen, the enterprise needs to make sense to
them (i.e., information generated should be useful to
their decision making). This is different from researchers
who monitor and assess for the sake of generating results
for, say, disseminating them to a broader scientific audi-
ence. Clinicians need to grasp the value of evaluation as
part of their usual practice, so that they understand the
importance of having data on important aspects of care
delivery that serve the purpose of sustaining change.
Summary
In this paper, we have summarized the concept of sustain-
ability by briefly reviewing how it has been characterized
by others, as well as what factors may affect it from organ-
izational and behavioral perspectives. We defined sustain-
ability as the continued use of core elements of an
intervention and persistent gains in performance as a
result of those interventions, which highlights the distinc-
tion made between measuring the potential to sustain as
part of an implementation project's FE, and measuring
whether usage and improved performance persisted after
implementation is completed and the project resources
are withdrawn. Finally, we made a number of recommen-
dations regarding the design of a sustainability analysis,
which are summarized in Table 4.
Table 4: Recommendations for designing a sustainability evaluation
WHAT TO MEASURE:
￿ Don't measure sustainability of interventions that were not useful or didn't achieve a credible level of success.
￿ Know what particular components of the intervention were actually implemented and/or adapted, and measure sustainability from both a process 
and outcome point of view.
￿ Understand the assignable causes of sustainability failure and success.
WHEN TO MEASURE IT:
￿ Allow enough time for performance to decline to its nadir.
￿ The longer the follow-up period, the better.
HOW TO MEASURE IT:
￿ Build in a follow-up evaluation into the original analytic plan to avoid later challenges, if possible.
￿ Use more than one method to triangulate qualitative information with quantitative data information.
￿ Talk directly to local stakeholders to understand the how and why behind
￿ performance measurements.
￿ Beware of drawing inappropriate conclusions (e.g., outcome attribution failure).
HOW TO GET FUNDED:
￿ Build the follow-up period into the original proposal if possible.
￿ Look for funding opportunities that explicitly include a sustainability component – either in the primary grant or through an allowable extension.
￿ For post hoc-designed analyses, look for small, rapid-response grants.
￿ Begin to routinize follow-up measurement as the responsibility of local stakeholders.Implementation Science 2008, 3:21 http://www.implementationscience.com/content/3/1/21
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Before a clear method for measuring the persistence of
change can be derived, we believe that there is a critical
need for the following:
￿ A wider use of FE in implementation studies that would
better inform measurement of post-implementation sus-
tainability success or failure,
￿ Availability of a wider array of instruments that measure
the important components of sustainability, and
￿ Inclusion of follow-up analyses built into an original
implementation design as a funding expectation.
Until these come about, evaluation of the period after
implementation will remain largely relegated to the "need
for further research" in most project write-ups. Ultimately,
a fuller elucidation of whether quality improvements
become institutionalized is needed to determine whether
subsidizing implementation of QI yields a sufficient
return on the funders' investments.
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